2015
DOI: 10.1016/j.jneuroim.2015.01.009
|View full text |Cite
|
Sign up to set email alerts
|

A possible association between elevated serum levels of brain-specific auto-antibodies and reduced plasma levels of docosahexaenoic acid in autistic children

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
3
0

Year Published

2015
2015
2025
2025

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(4 citation statements)
references
References 49 publications
1
3
0
Order By: Relevance
“…Overall, our data show for the first time that n-3 PUFA deficiency is a risk factor for the development of cognitive impairment in the context of MIA. This is in line with clinical data showing that n-3 PUFAs deficiency increases the risk of developing ADHD, autism or schizophrenia (Al-Farsi et al, 2013;Brigandi et al, 2015;Crippa et al, 2016;Hoen et al, 2013;Jory, 2015;Kirby et al, 2010;Mostafa et al, 2015;Parletta et al, 2016;Pawelczyk et al, 2015;Solberg et al, 2016;van der Kemp et al, 2012;Vancassel et al, 2001;Wiest et al, 2009). Conversely, interventional studies supplemented mothers and/or infants with n-3 PUFAs over the perinatal period with mixed results (Amminger et al, 2015(Amminger et al, , 2007Bent et al, 2011;Cooper et al, 2016;Dubnov-Raz et al, 2014;Gillies et al, 2012;Gould et al, 2014;Huss et al, 2010;Jiao et al, 2014;Mankad et al, 2015;McGorry et al, 2017;Meguid et al, 2008;Ooi et al, 2015;Politi et al, 2008).…”
Section: N-3 Pufa Deficiency Induces Memory Deficits In Mia-exposed A...supporting
confidence: 83%
“…Overall, our data show for the first time that n-3 PUFA deficiency is a risk factor for the development of cognitive impairment in the context of MIA. This is in line with clinical data showing that n-3 PUFAs deficiency increases the risk of developing ADHD, autism or schizophrenia (Al-Farsi et al, 2013;Brigandi et al, 2015;Crippa et al, 2016;Hoen et al, 2013;Jory, 2015;Kirby et al, 2010;Mostafa et al, 2015;Parletta et al, 2016;Pawelczyk et al, 2015;Solberg et al, 2016;van der Kemp et al, 2012;Vancassel et al, 2001;Wiest et al, 2009). Conversely, interventional studies supplemented mothers and/or infants with n-3 PUFAs over the perinatal period with mixed results (Amminger et al, 2015(Amminger et al, , 2007Bent et al, 2011;Cooper et al, 2016;Dubnov-Raz et al, 2014;Gillies et al, 2012;Gould et al, 2014;Huss et al, 2010;Jiao et al, 2014;Mankad et al, 2015;McGorry et al, 2017;Meguid et al, 2008;Ooi et al, 2015;Politi et al, 2008).…”
Section: N-3 Pufa Deficiency Induces Memory Deficits In Mia-exposed A...supporting
confidence: 83%
“…A positive association between anti-myelin basic protein (MBP) antibodies and low levels of the main n-3 PUFA found in the brain (docosahexaenoic acid, DHA) has been reported in autistic children [149]. Parental health questionnaires and red blood cell (RBC) fatty acid measurements have highlighted a decrease in DHA and total n-3 PUFAs in both autistic and Asperger patients.…”
Section: Risk Factors For Neuroinflammation and Autismmentioning
confidence: 99%
“…Essential fatty acids in three studies (two neutral and one negative ranking in the methodological quality) consistently reported significantly lower levels of linolenic acid (omega-3), linoleic acid (omega-6), arachidonic acid (AA) (omega-6), and docosahexaenoic acid (DHA) (omega-3) than controls [ 52 , 59 , 60 ]. However, the AA/DHA ratio was significantly higher in ASD-C in three studies [ 52 , 59 , 60 ], and significantly lower in one [ 42 ]. Although the results were inconsistent, there seems to be an imbalance in the omega-6/omega-3 ratio among ASD-C.…”
Section: Resultsmentioning
confidence: 99%